Loading clinical trials...
Loading clinical trials...
A Phase 1 Study to Evaluate the Effect of Steady State Solifenacin and Mirabegron on the Steady State Pharmacokinetics of Digoxin in Healthy Subjects
Conditions
Interventions
Mirabegron
Solifenacin
+1 more
Locations
1
Germany
Parexel International GmbH
Berlin, Germany
Start Date
March 1, 2014
Primary Completion Date
June 1, 2014
Completion Date
June 1, 2014
Last Updated
July 11, 2014
NCT06342713
NCT07052162
NCT06014515
NCT04961593
NCT07219940
NCT02456974
Lead Sponsor
Astellas Pharma Europe B.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions